A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II alpha

MLA

Bridget T. Hill, et al. “A Dual Mechanism of Action of the Anticancer Agent F 11782 on Human Topoisomerase II Alpha.” Biochemical Pharmacology, vol. 66, no. 4, Aug. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c200197e0c237bc5f634774bed399720&authtype=sso&custid=ns315887.

APA

Bridget T. Hill, John L. Nitiss, Peter Buhl Jensen, Maxwell Sehested, Lars H. Jensen, Karin C. Nitiss, & Axelle Renodon-Cornière. (2003). A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II alpha. Biochemical Pharmacology, 66(4).

Chicago

Bridget T. Hill, John L. Nitiss, Peter Buhl Jensen, Maxwell Sehested, Lars H. Jensen, Karin C. Nitiss, and Axelle Renodon-Cornière. 2003. “A Dual Mechanism of Action of the Anticancer Agent F 11782 on Human Topoisomerase II Alpha.” Biochemical Pharmacology 66 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c200197e0c237bc5f634774bed399720&authtype=sso&custid=ns315887.